Drug intelligence / Profile preview

OPF-109

Development stage
Unknown
Lead developer
Otsuka Pharmaceutical Factory, Inc.
Administration
Intravenous
01

Overview

**OPF-109** is an investigational, triple-bag central total parenteral nutrition formulation developed by Otsuka Pharmaceutical Factory for adults with chronic kidney disease or chronic renal failure who require parenteral nutritional support. The kit supplies dextrose, amino acids, potassium-free and phosphorus-free electrolytes, zinc, and an FDA 2000-recommendation-based multivitamin formulation; it is designed to provide concentrated nutrition while limiting fluid volume and avoiding potassium and phosphorus loading. In a completed Japanese Phase III trial, OPF-109 produced nutritional protein outcomes comparable with an active multi-product TPN control and increased circulating vitamin B1, vitamin B6, vitamin C, and folate concentrations. ([karger.com](https://karger.com/anm/article-pdf/82/1/36/4431171/000547656.pdf))

Beyond the preview

Go deeper on OPF-109.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OPF-109.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call